Where can biotech stocks go from here? RBC answers Nov 16, 2025 03:00PM
RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes' Sep 10, 2025 09:16AM
MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference May 13, 2025 07:00AM
RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA Jan 13, 2025 12:50PM
Mind Medicine (MNMD) Prices 9.29M Share Offering at $7/sh Aug 9, 2024 08:45AM


Aug 9, 2024 08:44AM Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering
Aug 9, 2024 06:18AM Mind Medicine (MNMD) Announces Proposed Share Offering
Aug 9, 2024 06:00AM Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
Jun 5, 2024 06:14AM RBC Capital Reiterates Outperform Rating on MindMed (MNMD)
Mar 7, 2024 07:15AM Mind Medicine (MNMD) Prices 16.67M Share Offering at $6/sh
Mar 7, 2024 07:13AM Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
May 4, 2023 04:02PM MindMed Reports First Quarter 2023 Financial Results and Business Highlights
May 2, 2023 08:00AM MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy
Apr 26, 2023 07:00AM MindMed to Participate in May Investor Conferences
Nov 16, 2022 05:08AM UPDATE: RBC Capital Starts MindMed (MNMD) at Outperform, 'Practical Pursuit Of Psychedelic Promise'
Sep 28, 2022 05:58AM Mind Medicine (MNMD) Prices 7.06M Share Offering at $4.25/sh
Sep 27, 2022 11:47PM MindMed Announces Pricing of Public Offering of Common Shares and Warrants
Sep 27, 2022 04:18PM Mind Medicine (MNMD) Announces Proposed Stock Offering, Size not Disclosed
Sep 27, 2022 04:17PM MindMed Announces Proposed Public Offering of Common Shares